Mealey's (June 6, 2018, 11:46 AM EDT) -- HUNTINGTON, W.Va. — A West Virginia federal judge on May 31 granted partial summary judgment in a Pradaxa death case, saying the plaintiffs cannot argue that the lack of an antidote for the anticoagulant is a design defect (Claude R. Knight, et al. v. Boehringer Ingelheim Pharmaceuticals, Inc., et al., No. 15-6424, S.D. W.Va., Huntington Div., 2018 U.S. Dist. LEXIS 92764)....